Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer (SCLC): Final results. This is an ASCO Meeting Abstract from the 2012 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback